According to our new research report, “Asia Pacific Biotechnology Market (2008-2012)”, the Asia-Pacific biotech market is projected to grow at a CAGR of around 19% during 2010 - 2013. Growth of the biotech industry in the region will be headed by Japan, China, and South Korea, while higher growth rates will be witnessed in emerging markets, such as Malaysia, India, and Singapore.
The Asia Pacific biotech market will grow due to the upsurge in biosimilars, agri-biotech, and industrial biotech markets. While the biosimilars market will grow due to the flurry of patent expirations in near future, issues of food security will drive the agri-biotech sector. Hence, most of the biotech companies in the region are focusing on these sectors, and many other companies are planning their foray through planned investments and collaborations.
Our report, “Asia Pacific Biotechnology Market (2008-2012)”, also discusses the emerging sectors, such as contract research and manufacturing, biobetters, bioinformatics, generics market etc. The report provides valuable information to pharmaceutical & biotechnology companies and investors, planning to enter these markets and will help them in devising strategies in accordance to the individual markets. The report also contains detail analysis and statistics of the market size, growth, share, segmentation, geographic distribution, trends in technology development, and profiling of key players of each country.
For FREE SAMPLE of this report visit: http://www.rncos.com/
Check DISCOUNTED REPORTS on: http://www.rncos.com/
# # #
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.